Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ALTANA PHARMA

Home Clinical Trial Sponsors and OrganizationsALTANA PHARMA

ALTANA PHARMA

6563 Rosemont Ln, Mason, Ohio, United States

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

3

3 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

No trial phase data available

Trial Status Distribution

Active, not recruiting

3

100.0%

Clinical Trials

Trials sponsored by this organization (3)

Comparison of the Efficacy and Safety of 160 mcg Ciclesonide Administered Once Daily in the Evening with ot without Different Spacer Types in Patients with Asthma

Active, not recruiting

Nov 200548 participants

500 mcg roflumilast once daily in combination with 50 mcg salmeterol twice daily versus 50 mcg salmeterol twice daily alone over 52 weeks in patients with COPD. A double blind, parallel group, phase IIIb clinical study.

Active, not recruiting

Comparison of inhaled ciclesonide (640 g/day) and fluticasone propionate (1000 g/day) in patients with moderate and severe persistent asthma.

Active, not recruiting

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials3
Approvals
News

Back to Organizations